Search Tag: #ESC17

2017 06 Sep

A presentation on the 2017 ESC peripheral arterial diseases (PADs) was carried out at this year’s European Society of Cardiology Congress 2017. The session centred on the importance of these conditions in the cardiac context while exploring the importance of collaboration between cardiologists and vascular surgeons—indeed the essence of good...Read more

2017 06 Sep

During one of the Hot Line trials that took place at the European Society of Cardiology 2017 in Barcelona, late-breaking results revealed that patients who used a mobile heart monitoring device to record an ECG were almost four times more likely to be diagnosed with atrial fibrillation (AF) than patients receiving routine care. AF is...Read more

2017 31 Aug

According to late-breaking results from the PRECISION-ABPM study (Prospective Randomised Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) which was presented during a Hot Line Clinical Trial at the European Society of Cardiology Congress 2017, Ibuprofen is associated with increased...Read more

2017 31 Aug

A historic turning point in cardiology took place at this year’s European Society of Cardiology Congress 2017  in Barcelona, as a host of seminal, practice-changing data was presented.   One major highlight included the landmark CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) study which showed that reducing inflammation,...Read more

2017 28 Aug

The incidence of previously undiagnosed atrial fibrillation (AF) may be substantial in patients with risk factors for AF and stroke, according to a study presented at the European Society of Cardiology Congress 2017. By using implanted cardiac monitors, researchers detected nearly 30 percent of previously undiagnosed AF after 18 months in this high-risk...Read more